Jonae Barnes | Senior VP, Investor Relations & Corporate Communications |
Jean Sommadossi | Founder, Chairman & CEO |
Andrea Corcoran | CFO & Executive VP, Legal |
Janet Hammond | Chief Development Officer |
Arantxa Horga | Chief Medical Officer |
Roanna Ruiz | SVB Leerink |
Jessica Hui | Evercore |
Good afternoon, ladies and gentlemen. Welcome to the Atea Pharmaceuticals' Fourth Quarter and Full Year 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. [Operator Instructions] Please be advised that today’s conference is being recorded.